Cytek Biosciences Management
Management criteria checks 1/4
Cytek Biosciences' CEO is Wenbin Jiang, appointed in Dec 2014, has a tenure of 9.92 years. total yearly compensation is $4.94M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 4.03% of the company’s shares, worth €32.38M. The average tenure of the management team and the board of directors is 3.6 years and 2.9 years respectively.
Key information
Wenbin Jiang
Chief executive officer
US$4.9m
Total compensation
| CEO salary percentage | 11.7% |
| CEO tenure | 9.9yrs |
| CEO ownership | 4.0% |
| Management average tenure | 3.6yrs |
| Board average tenure | 2.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$10m |
| Jun 30 2024 | n/a | n/a | -US$18m |
| Mar 31 2024 | n/a | n/a | -US$12m |
| Dec 31 2023 | US$5m | US$578k | -US$12m |
| Sep 30 2023 | n/a | n/a | -US$14m |
| Jun 30 2023 | n/a | n/a | -US$6m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$4m | US$524k | US$2m |
| Sep 30 2022 | n/a | n/a | -US$901k |
| Jun 30 2022 | n/a | n/a | -US$3m |
| Mar 31 2022 | n/a | n/a | -US$2m |
| Dec 31 2021 | US$5m | US$375k | US$52k |
| Sep 30 2021 | n/a | n/a | US$575k |
| Jun 30 2021 | n/a | n/a | US$2m |
| Mar 31 2021 | n/a | n/a | US$4m |
| Dec 31 2020 | US$422k | US$241k | US$3m |
Compensation vs Market: Wenbin's total compensation ($USD4.94M) is above average for companies of similar size in the German market ($USD1.46M).
Compensation vs Earnings: Wenbin's compensation has increased whilst the company is unprofitable.
CEO
Wenbin Jiang (60 yo)
9.9yrs
Tenure
US$4,939,242
Compensation
Dr. Wenbin Jiang, Ph D., is co-founder, Chairman and President of Cytek Biosciences, Inc and has been its Chief Executive Officer and Director since December 2014. Dr. Jiang is a seasoned entrepreneur and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.9yrs | US$4.94m | 4.03% € 32.4m | |
| CTO & Director | 9.8yrs | US$3.07m | 4.67% € 37.6m | |
| Chief Legal Officer & Corporate Secretary | 3.8yrs | US$1.86m | 0.049% € 392.2k | |
| Senior Vice President of Business & Corporate Development | 3.6yrs | US$1.43m | 0.047% € 374.4k | |
| Head of Corporate Development Analytics | less than a year | US$1.79m | 0.076% € 608.3k | |
| Chief Financial Officer | less than a year | no data | no data | |
| Senior Vice President of Global Sales & Services | 1.3yrs | no data | 0.010% € 80.3k |
3.6yrs
Average Tenure
60yo
Average Age
Experienced Management: 8EQ's management team is considered experienced (3.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 9.9yrs | US$4.94m | 4.03% € 32.4m | |
| CTO & Director | 9.8yrs | US$3.07m | 4.67% € 37.6m | |
| Independent Director | 2.4yrs | US$215.67k | 0% € 0 | |
| Independent Director | 2.4yrs | US$217.50k | 0% € 0 | |
| Lead Independent Director | 6.2yrs | US$260.00k | 0.021% € 168.5k | |
| Independent Director | less than a year | no data | 0.0028% € 22.7k | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 2.9yrs | US$215.00k | 0% € 0 |
2.9yrs
Average Tenure
62yo
Average Age
Experienced Board: 8EQ's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.